Pacific Biosciences of California Inc. buy Zacks Research
Start price
21.02.26
/
50%
€1.34
Target price
21.02.27
-
Performance (%)
-4.11%
Price
31.07.26
€1.21
Summary
This prediction is currently active. With a performance of -4.11%, the BUY prediction for Pacific Biosciences of California Inc. by Zacks_Research is down slightly. This prediction currently runs until 21.02.27. The prediction end date can be changed by Zacks_Research at any time. Zacks_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pacific Biosciences of California Inc. | 1.171% | 1.171% |
| iShares Core DAX® | 2.591% | 2.691% |
| iShares Nasdaq 100 | -0.915% | -7.368% |
| iShares Nikkei 225® | 0.145% | -10.196% |
| iShares S&P 500 | -0.367% | -0.833% |
Comments by Zacks_Research for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California (NASDAQ:PACB) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Ratings data for PACB provided by MarketBeat